Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Nashmin Fayazi"'
Autor:
Hosseini, Nashmin Fayazi, Amini, Razieh, Ramezani, Mohammad, Saidijam, Massoud, Hashemi, Seyed Mahmoud, Najafi, Rezvan
Publikováno v:
In Biomedicine & Pharmacotherapy November 2022 155
Autor:
Manoochehri, Hamed, Hosseini, Nashmin Fayazi, Saidijam, Massoud, Taheri, Mohammad, Rezaee, Hamideh, Nouri, Fatemeh
Publikováno v:
In Biocatalysis and Agricultural Biotechnology May 2020 25
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Biotechnology Letters
It only took 8 months for the pneumonia caused by a previously unknown coronavirus to turn into a global pandemic of unprecedentedly far-reaching implications. Failure of the already discovered treatment measures opened up a new opportunity to evalua
Autor:
Nashmin Fayazi Hosseini, Razieh Amini, Mohammad Ramezani, Massoud Saidijam, Seyed Mahmoud Hashemi, Rezvan Najafi
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 155
Severe side effects of chemotherapy agents on vital organs are the major causes of cancer-related mortality, not merely cancer disease. Encapsulating chemotherapeutic molecules in nanocarriers is a justifiable solution in decreasing the risk of their
Autor:
Nashmin Fayazi Hosseini
Publikováno v:
Current Molecular Medicine. 21:96-110
Autor:
Nashmin Fayazi Hosseini, Fateme Karimi Dermani, Sara Malih, Saeideh Gholamzadeh Khoei, Mohsen Sheykhhasan
Publikováno v:
Current Stem Cell Research & Therapy. 15:623-638
Background: Cardiovascular disease (CVD), including disorders of cardiac muscle and vascular, is the major cause of death globally. Many unsuccessful attempts have been made to intervene in the disease's pathogenesis and treatment. Stem cell-based th
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maryam Akhoundi, Mahsa Mohammadi, Nashmin Fayazi, Mohsen Sheykhhasan, Seyedeh Saeideh Sahraei
Background Chimeric antigen receptor (CAR)-modified T cell therapy has shown great potential in the immunotherapy of patients with hematologic malignancies. In spite of this striking achievement, there are still major challenges to overcome in CAR T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db94d3abc1dc30ec48bc32ce85d0ef7f
https://doi.org/10.21203/rs.3.rs-203368/v1
https://doi.org/10.21203/rs.3.rs-203368/v1
Autor:
Nashmin Fayazi Hosseini, Paola Dama, Mohsen Sheykhhasan, Hamid Tanzadehpanah, Mohammad Akbari, Reihaneh Seyedebrahimi, Yaghoub Ahmadyousefi, Mohsen Eslami Farsani, Hamed Manoochehri
Publikováno v:
Expert Reviews in Molecular Medicine. 23
Long non-coding RNAs (lncRNAs) have important roles in regulating the expression of genes and act as biomarkers in the initial development of different cancers. Increasing research studies have verified that dysregulation of lncRNAs occurs in various